A photo of Nat Nasomyont.

Assistant Professor, UC Department of Pediatrics

513-636-4744

Board Certified

My Biography & Research

Clinical Interests

Pediatric endocrinology; metabolic bone disease; pediatric osteoporosis; transgender health; diabetes

Research Interests

Metabolic bone disease; pediatric osteoporosis

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Clinical Divisions

Endocrinology

Research Divisions

Endocrinology

My Locations

My Education

MD: Siriraj Hospital Faculty of Medicine, Bangkok, Thailand, 2011.

Residency: Pediatrics, University of South Alabama, Mobile, AL, 2017.

Fellowship: Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2020.

MS: Clinical and Translational Research, University of Cincinnati, Cincinnati, OH, 2020.

Certification: American Board of Pediatrics, 2017; Certified Clinical Densitometrist (CCD), 2020.

My Publications

Selected Publication

Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review. Nasomyont, N; Hornung, LN; Gordon, CM; Wasserman, H. Bone. 2019; 121:60-67.

Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy. Nasomyont, N; Keefe, C; Tian, C; Hornung, L; Khoury, J; Tilden, JC; Hochwalt, P; Jackson, E; Rybalsky, I; Wong, BL; et al. Osteoporosis International. 2020; 31:2449-2459.

Intravenous bisphosphonate therapy in children with spinal muscular atrophy. Nasomyont, N; Hornung, LN; Wasserman, H. Osteoporosis International. 2020; 31:995-1000.

Central Diabetes Insipidus in a Patient With NFKB2 Mutation: Expanding the Endocrine Phenotype in DAVID Syndrome. Nasomyont, N; Lindsley, AW; Assa'ad, A; Dawson, DB; Neilson, DE; Brady, CC; Rutter, MM. Journal of Clinical Endocrinology and Metabolism. 2019; 104:4051-4057.

Growth Hormone Therapy for Turner Syndrome. Blunden, C; Nasomyont, N; Backeljauw, P. Pediatric Endocrinology Reviews PER. 2018; 16:80-90.